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Fat mass and obesity-associated (FTO) gene influences obesity but studies have shown that environmental/lifestyle variables like
physical activity (PA), time spent sitting (TSS), and energy intake might mediate the effect. However, this is poorly understood
in Nigeria due to scarce studies. We demystified association and interaction between FTO rs9939609, obesity, PA, TSS, and
energy intake in Nigeria. FTO gene variant was genotyped by restriction fragment length polymorphism and gene sequencing
analysis in 103 people with obesity and 98 controls. Anthropometrics and environmental variables were measured using standard
procedures. Significant associations were found between FTO rs9939609 with obesity and environmental/lifestyle variables before
and after adjusting for age. Carriers of allele A have significantly higher odds of being overweight/obese using BMI [0.191
(0.102–0.361), 𝑝 < 0.001] but this was attenuated by PA (𝑝[interaction] = 0.029); odds of being overweight reduced from 0.625
(0.181–2.159) to 0.082 (0.009–0.736) for low and high PA, respectively. Mediation analysis of total indirect effect also confirmed
this by showing a simultaneous mediating role of total PA, energy intake, and TSS in the relationship between FTO and BMI
(unstandardized-coefficient = 1.68; 95% CI: 1.26–2.22). This study shows a relationship between FTO and obesity phenotype and
environmental/lifestyle factors might be an important modulator/mediator in the association.
1. Introduction
Increasing number of overweight/obese people has con-
tributed immensely to public health challenge throughout
the world. Studies in Nigeria had reported a higher rate of
obesity and cardiovascular risk factors [1]. Thus Nigeria is
not exempted from the scourge. Therefore, there is the need
for greater attention and proactive step to stem the tide. The
interactions between environmental and individual factors,
including genetic makeup, explain the variability in body size
between individuals in a given population [2–5], implying
that gene-environment interaction might be germane in the
development/progression of overweight/obesity [6].
One of the most known genetic factors predisposing
humans to nonmonogenic obesity is a polymorphism in
the fat mass and obesity-associated (FTO) gene [7, 8] espe-
cially first intron rs9939609 (A/T variant) [9–12]. Individuals
carrying this risk allele have been reported to have about
1.09 kg, 0.54 kg/m2, and 1.07 cmmore weight, BMI, and waist
circumference (WC), respectively [10]. However, there are
still many unknown attributes regarding the biology of this
locus [5, 6].
Human carriers of the susceptible single nucleotide poly-
morphisms (SNPs) in FTO (rs9939609A/T variant) have also
been shown to have a strong relationship with satiety and
Hindawi
Journal of Obesity
Volume 2017, Article ID 3245270, 11 pages
https://doi.org/10.1155/2017/3245270
2 Journal of Obesity
nutrient preference; this suggests that FTOvariant is germane
in the dietary macronutrient composition of an individual
[5]. To lend credence to this, a recent study suggested that
there was FTO (rs9939609 A/T variant) genotype-specific
enhancement of neural sensitivity to food stimuli. Thus it
seems to be predisposing individual to addiction-supportive
food perception [13, 14]. However, Gustavsson et al. [15]
reported no evidence of interactions between FTO genotype
andmacronutrient intake on cardiovascular heart disease risk
or BMI. This might be a result of the difference in genetic
and environmental variables of their study population; it thus
shows that genetic and environmental factors are germane in
demystifying obesity.
A high ratio of second to fourth digit finger length
(2D : 4D) is widely associated with increased BMI, body size,
and coronary heart disease [16–18]. Thus it might be related
to the FTO rs9939609 gene variant. Several studies have
elucidated the effects of environment and FTO variant on
obesity, evident in the well-studied time spent sitting (TSS),
physical activity (PA), and dietary correlates of obesity [9,
10, 12, 19]. The first study on FTO gene polymorphism in
a well-characterized African (Gambians living in traditional
lifestyle) reported that FTO gene variant seems not to
influence BMI [20]. But this is slowly being understood in
Nigerian context due to limited reports. Studies have shown
that some anthropometric variables (ratio of second to the
fourth finger (2D : 4D), WC, neck circumference (NC), waist
to height ratio (WHtR), and waist to hip ratio (WHR))
might be a surrogate marker for overweight/obesity [21–23].
This study explored those anthropometric traits relationship
with FTO rs9939609 variant and the modulating roles of
environmental variables (PA, TSS, and energy intake) among
young adults. This study combined gene sequencing and
restriction fragment length polymorphism (RFLP) to unravel
FTO polymorphism in Nigeria population.
2. Materials and Methods
This case-control pilot study was conducted among ran-
domly selected unrelated young adults with the mean age
of 22.6 (103 people with obesity [BMI ≥ 25.0 Kg/m2] and
98 controls) at the Federal Polytechnic Ado-Ekiti (FPA),
Nigeria. The study (including informed consent forms and
the proposed participant recruitment strategy) was approved
by the Research Ethics Committee of the Ekiti State Teaching
Hospital Ethical Committee and the FPA Ethical Committee
(approval number: FPA/ETH/13-028). We conducted this
study in accordance with the Declaration of Helsinki, and all
participants gave written informed consent.
Digit length was measured as previously described by
Manning et al. [24]. Briefly, subjects kept their hands supine
on a flat surfacewith the palm facing up and the digits straight
in the same plane and fingers wide opened in a posture of ease
(not kept together tight under artificial pressure).
Body weight, height, WC, HC, and NC were measured
with standard procedure while BMI, WHtR, and WHR were
calculated as weight (kg) divided by height (m) squared, WC
divided by height, and WC divided by HC, respectively.
PA and TSS were measured with self-reported Inter-
national Physical Activity Questionnaire-Short (IPAQ-SF)
form which had been adapted to one of the Nigeria major
languages by [25]. Total physical activity was computed and
categorized as described by http://www.ipaq.ki.se. Briefly,
each category of physical activity was multiplied by their
estimated intensity (MET) and reported day(s); the sum of
all categories was the total physical activity of the individual.
MET intensity includes vigorous (8 METs), moderate (4
METs), andwalking (3.3METs).OneMET is the energy dissi-
pated in an inactive state which is 3.5mL/kg/min of VO2 [26].
We used semiquantified food frequency questionnaire
(FFQ) to collect information about the dietary habits of our
participants as described by [27].
Genomic DNA was isolated from EDTA-anticoagulated
whole blood samples using Quick-gDNAMiniPrep kits
(ZymoResearch, USA) according to the manufacturer’s pro-
tocol and stored at –20∘C. Genotyping of SNP in rs9939609
was done with PCR-RFLP assay as described by [28]. Briefly,
genomic DNA (20 ng) was incubated in a 10 𝜇L solution
containing 1 NH4 buffer, 2.5mmol/liter magnesium, 200
𝜇mol/liter each dNTP, 20 pmol forward (5󸀠-AACTGGCTC-
TTGAATGAAATAGGATTCAGA-3󸀠) and reverse (5󸀠-AGA-
GTAACAGAGACTATCCAAGTGCAGTAC-3󸀠) oligonucle-
otide primers, and 0.5U Taq DNA polymerase (Inqaba West
Africa). The PCR mix was incubated using a touchdown
programme at 94∘C for 2 minutes followed by 35 cycles of
93∘C for 15 seconds, 65∘C–56∘C for 20 seconds (dropping
0.5∘C per cycle), 72∘C for 30 seconds, 72∘C for 5 minutes, and
10∘C∞. This was then incubated at 37∘C for 3 hours with 2U
ScaI (Inqaba, West Africa). Genotype success rate was 98%.
To confirm results from PCR-RFLP, we proceeded to
sequence analysis of the FTO rs9939609 gene: sequencing
reactions were performed using the ABI Big Dye Termi-
nator Cycle Sequencing kit version 3.1 (Applied Biosystems
Inc., Foster City, CA). Cycling conditions include 94∘C/1
minute; 25 cycles of 96∘C/10 seconds, and 60∘C/4 minutes.
Reactions were carried out in a total volume of 20 𝜇L,
which included 1–3 ng/𝜇L purified PCR product, 3.2 pmol
primer, and 8 𝜇L ABI Prism Big Dye Terminator mix, v3.1
(Applied Biosystems).The sequencing products were cleaned
using the ZR-96 DNA Sequencing Clean-up kitTM (Zymo
Research Corporation©, Irvine, CA, 2005-2006). Products
were analyzed on the Applied Biosystems/Hitachi 3130 9-1-
Genetic Analyser. The FTO rs9939609 gene was sequenced
bidirectionally in every participant to confirm the observed
variants.
2.1. Statistical Analysis. Statistical analysis was performed
using IBM SPSS 22 and GraphPad Prism 7 for Mac while
sample size was computed using G∗Power (version 3.1;
Heinrich Heine University, Du¨sseldorf, Germany) [29] and
method described by Viechtbauer et al. [30] for a pilot study.
Power, significance, and minor or risk allele frequencies
(MAF) for cases and controls were 95%, 5%, 40%, and 27%,
respectively; thus our sample size appears to be sufficient for
pilot study.
Data are expressed as frequencies and percentage or as
means (standard deviation) unless otherwise stated. Allelic
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Figure 1: Multiple mediation models of the relationship between FTO rs9939609, TPA, energy intake, TSS, and BMI. (TPA, energy intake,
and TSS are mediators). Standardized coefficients are presented and tested for significance with 95% confidence intervals calculated using
the bias-corrected bootstrap method (5000 samples). a = standardized IV to Med coefficient, b = standardized Med to DV coefficient, c =
standardized total effect (IV to DV), and c1 = specific indirect effect (indirect path). ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001. BMI: body mass index, TPA:
total physical activity, TSS: time spent sitting, IV: independent variable, DV: dependent variable, and Med: mediator.
and genotypic frequencies were determined by counting the
genotypes and distribution of genotypes in different groups
was compared by Chi-square or Fisher exact test. Robust
logistic regression was used to evaluate the associations
between the FTO rs9939609 genotype (genotype coded as 0
for TT, 1 for AT, and 2 for AA), obesity measures, 2D : 4D,
and energy intake (controlled for sex and age). Models were
also created for the categorical outcome (overweight/obesity
versus control) by robust logistic regression where FTO
rs9939609 was included. Analyses were adjusted for sex and
age, and odds ratios (OR) with 95% confidence intervals
(CI) were calculated to estimate the association between
genotypes and measurements. Differences were checked by
T-test and ANOVA (Significant ANOVA results were further
examined using the Bonferroni post hoc test). Differences
in data that did not follow a normal distribution (physical
activity) were analyzed with nonparametric Kruskal–Wallis
and Mann–Whitney tests.
A statisticalmethodwhich is known as tests ofmediation,
which examines the effect of a presumed mediator(s) on the
outcome of a predictor on the response variable, is used
to investigate possible mediating effects of PA, TSS, and
energy intake on the association between our distal variable
(FTO rs9939606 genotype) and outcome (BMI). In recent
times, studies have employed this method for mediating
analysis of mediator(s) on obesity risk allele and BMI [9, 31].
We followed approaches developed by [32] for the multiple
mediation analysis on our mediators on the relationship
between FTO rs9939609 and BMI. Briefly, we named path
coefficient linking the predictor with mediators and path
coefficient of a mediator to the outcome as paths 𝑎 and 𝑏,
respectively. Paths c and c󸀠 refer to the total and indirect effect
of FTO rs9939609on BMI in the absence and presence of the
mediators, respectively (Figure 1). Bootstrapping was used to
create 95% confidence intervals around the “true” value of
this cross-product (referred to as the indirect effect). If zero
is not within this confidence interval, then the indirect (i.e.,
mediating) effect is significant. The SPSS “indirect” macro
developed to accompany the paper by [32] was used to test
the significance.We also checked themediating effect of each
mediator separately and of BMI on the association of FTO
rs9939609 on TSS using the same method described above.
A 𝑝 value < 0.05 was considered to have statistical
significance.
3. Results
We arrived at the sample size with G∗Power (version 3.1;
Heinrich Heine University, Du¨sseldorf, Germany) [29] and
method described by Viechtbauer et al. [30] for a pilot study.
Power, significance, and MAF for cases and controls were
95%, 5%, 40%, and 27%, respectively. Thus our sample size
appears to be sufficient for this pilot study.
The demographics of the two hundred and one unrelated
participants (age range from 17 to 39 years) stratified by sex
are presented in Table 1; 51.20%, 32.3%, 53.2%, and 54.7%
of individuals were people with obesity using BMI, WC,
WHR, and WHtR benchmarks. Cutoff values include BMI ≥
25.0 kg/m2, WC ≥ 80.0 cm for female and ≥94.0 cm for male,
and WHR ≥ 0.45 for female and ≥0.5 for male while values
≥0.5 were used forWHtR in both sexes.There was a statistical
difference in total physical activity in female andmale but not
time spent sitting. The ratio of second and fourth digits of
both hands was also different (2D : 4D) (Table 1).
All participants were genotyped for FTO SNP rs9939609;
thirty-six (17.9%) were homozygous for the obesity risk allele
(AA), 90 (44.8%) were heterozygous (AT), and 75 (37.3%)
were wild type (TT). The frequency of allele A in this study
is 0.40, while it is 0.53 and 0.27 for overweight/obesity and
healthy control, respectively. None of these allelic frequencies
differs from Hardy-Weinberg equilibrium (𝑝 > 0.05).
We reported significantly high obesity risk factors in AA,
followed by AT and TT, respectively, while the opposite was
reported in physical activity pattern (Table 2, Supplemen-
tary Table 1, and Supplementary Figures 1–4 in Supplemen-
tary material available online at https://doi.org/10.1155/2017/
3245270). As shown in Table 3 and Supplementary Figures 1
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Table 1: Characteristics of the study population.
Characteristics Overall(𝑛 = 201)
Female
(𝑛 = 102)
Male
(𝑛 = 99) 𝑝
Age (years) 22.64 (3.61) 23.05 (3.69) 22.22 (3.50) 0.105
Anthropometric
Body weight (kg) 66.98 (9.54) 62.54 (7.80) 71.56 (9.03) <0.001
BMI (kg/m2) 25.96 (3.06) 25.52 (3.15) 26.41 (2.91) 0.044
Normal (n; %)a 98; 48.80 45; 22.40 53; 26.40 0.182
Overweight/obesity (n; %)b 103; 51.20 57; 28.40 46; 22.90 0.322
NC (cm) 31.24 (4.00) 30.78 (5.06) 31.25 (4.34) 0.121
WC (cm) 81.67 (8.02) 80.91 (7.50) 82.47 (8.48) 0.169
Central obesity (n; %)c 65; 32.30 56; 27.90 9; 4.50 <0.001
WHR 0.881 (0.081) 0.862 (0.070) 0.899 (0.088) 0.001
Central obesity (n; %)d 107; 53.20 57; 28.40 50; 24.90 0.445
WHtR 0.507 (0.055) 0.514 (0.053) 0.499 (0.056) 0.038
Visceral obesity (n; %)e 110; 54.70 62; 30.80 48; 23.90 0.08
R2D : 4D 0.9711 (0.027) 0.9819 (0.027) 0.9600 (0.022) <0.001
L2D : 4D 0.9684 (0.024) 0.9791 (0.023) 0.9573 (0.021) <0.001
Energy intake (kcal/day)f 1848.76 (431.17) 1763.73 (397.96) 1936.36 (448.23) 0.004
Time spent siting (minutes/week) 411.19 (183.12) 400.98 (173.53) 421.72 (192.82) 0.424
Physical activity (PA)
Total PA (MET-minutes/week)∗∗ 678 (4177–40) 643.5 (3405–40) 1335 (4177–188.5) <0.001
Light PA (MET-minutes/week)∗∗ 396 (1782–0) 280.5 (1782–0) 495 (1782–33) <0.001
Moderate PA (MET-minutes/week)∗∗ 180 (1800–0) 120 (1800–0) 320 (1680–0) <0.001
Vigorous PA (MET-minutes/week)∗∗ 80 (1800–0) 0 (1800–0) 80 (1800–0) 0.072
Data are presented as means (standard deviation (SD) values shown in parenthesis) except stated otherwise.The difference was evaluated using Student’s T-test
and Chi-square test for continuous and categorical variables, respectively; BMI: body mass index, NC: neck circumference, WC: waist circumference, WHR:
waist to hip ratio, WHtR: waist to height ratio, R2D : 4D: ratio of right hand second to fourth digit, and L2D : 4D: ratio of left hand second to the fourth digit; n
= number of samples; % = percentage; anormal BMI < 25 kg/m2 while boverweight/obesity BMI ≥ 25 kg/m2; ccentral obesity was defined as WC > 80 cm for
female and > 94 cm for male; dcentral obesity was defined asWHR > 0.85 for female and >0.90 for male; evisceral obesity was defined as WHtR > 0.5; f total
energy intake per day from carbohydrate sources; ∗∗data expressed by median (range); Mann–Whitney U test.
and 2, presence of at least one copy of the risk allele (A) was
associated with some units higher (𝛽) obesity risk factors as
categorized by body weight (𝛽: 3.11 kg per risk allele, 95% CI:
0.39–5.83, 𝑝 < 0.001), BMI (𝛽: 1.74 kg/m2 per risk allele, 95%
CI: 0.89–2.58, 𝑝 < 0.001), WC (𝛽: 5.73 cm per risk allele, 95%
CI: 3.58–7.88, 𝑝 < 0.001), and NC (𝛽: 2.55 cm per risk allele,
95% CI: 1.45–3.65, 𝑝 < 0.001). We also observed that 2D : 4D
in both hands showed marked increased in individuals with
the risk allele (𝛽: 0.018 per risk allele, 95% CI: 0.011–0.025,
𝑝 < 0.001 and 𝛽: 0.016 per risk allele, 95% CI: 0.010–0.022,
𝑝 < 0.001) for right and left hand, respectively (Table 3
and Supplementary Figure 3). A similar trend was observed
for energy intake (354.4 Kcal/day more per risk allele) and
TSS (190.5 minutes more per risk allele) (Tables 2 and 3 and
Supplementary Figure 4).
Participants with FTO risk allele (A) had significantly
higher odds of being overweight/obese (OR: 0.19 (0.10–0.36),
𝑝 < 0.001), central obesity (OR: 0.33 (0.15–0.71), 𝑝 = 0.005),
and visceral obesity (OR: 0.12 (0.06–0.23), 𝑝 < 0.001) than
individuals with the T allele only (Table 3). But the odds were
attenuated with increased physical activity levels as shown in
Table 4. The odds of overweight/obesity reduced from 0.63
(95% CI: 0.18–2.16) per copy of the risk allele in participants
with lower levels of PA to 0.08 (95% CI: 0.009–0.736) in
participants with high PA (𝑝(interaction) = 0.029) (Table 4).
Similar odds trends were found in WHR central obesity
(low PA: 0.517 versus high PA: 0.057 per copy of the risk
allele, 𝑝(interaction) = 0.007) and WHtR visceral obesity (low
PA: 0.356 versus high PA: 0.142 per copy of the risk allele,
𝑝(interaction) = 0.010). This was further confirmed in Figures
2–4 where the least square mean of obesity traits in FTO
genotypes is different in low and high PA. There was also
gene-PA interaction effect on energy intake and time spent
sitting with significant 𝑝(FTO∗PA) interaction values of 0.008
and 0.027 was reported, respectively (Figure 4). From the
preceding,wemight predict that there aremediating effects of
PA, TSS, and energy intake on BMI, thus mediation analysis.
Multiple regression analyses were conducted to assess
effects of mediator(s) on the relationship between FTO
rs9939609 and BMI using mediation model. First, it was
found that FTO rs9939609 variant was associated with BMI
(𝐵 = 1.34, t(199) = 4.68, and 𝑝 < 0.001) (path 𝑐). It was also
found that FTO rs9939609 variant was significantly related
to all mediator TPA (𝐵 = −615.96, t(199) = −5.69, and
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Table 2: Anthropometric traits of overweight and control subjects stratified by FTO rs6639609 variants.
Characteristics Overall (𝑛 = 201) TA (𝑛 = 90) AA (𝑛 = 36) 𝑝
TT (𝑛 = 75)
Body weight (kg) 65.03 (8.04)a 66.67 (10.49)a 71.82 (8.47) 0.007a
BMI (kg/m2) 24.95 (2.50)a 26.10 (3.24)a 27.70 (2.88) 0.006a
NC (cm) 29.72 (2.63)a 30.91 (3.78)a 35.20 (4.39) <0.001a
WC (cm) 78.20 (7.14) 82.70 (7.46) 86.33 (8.21) 0.026
WHtR 0.481 (0.05) 0.519 (0.05)a 0.532 (0.06)a 0.006a
WHR 0.840 (0.07) 0.883 (0.07) 0.957 (0.08) 0.002
R2D : 4D 0.9586 (0.02) 0.9742 (0.02) 0.9894 (0.04) 0.0026
L2D : 4D 0.9570 (0.02) 0.9726 (0.02) 0.9816 (0.03) 0.013
Energy intake (kcal/day) 1662.00 (377.76) 1891.67 (370.25) 2273.89 (537.91) 0.008
TSS (minutes/week) 300.13 (129.75) 465.22 (151.73) 541.94 (160.62) 0.003
TPA∗∗ 1668.00 (4177–99) 625.25 (4120–40) 645.00 (2826–89.5) <0.001
VPA∗∗ 792.00 (1782–0) 297.00 (1782–0) 231.00 (1386–33) <0.001
MPA∗∗ 480.00 (1800–0) 170.00 (1760–0) 120.00 (1440–0) <0.001
LPA∗∗ 96.00 (1800–0) 0 (1680–0) 0 (1800–0) 0.066
Data are expressed as mean (SD values presented in parenthesis) except stated otherwise; ANOVA test (Bonferroni multiple comparability test) was used to
compare means across genotype while Kruskal–Wallis test was used to test the difference in physical activity; BMI: body mass index, NC: neck circumference,
WC: waist circumference, WHR: waist to hip ratio, WHtR: waist to height ratio, R2D : 4D: ratio of right hand second to fourth digit, and L2D : 4D: ratio of left
hand second to fourth digit; TSS: time spent sitting, TPA: total physical activity, VPA: vigorous physical activity, MPA: moderate physical activity, and LPA: low
physical activity; adata expressed with the same superscript in the same row are not statistically different at 𝑝 < 0.05; ∗∗data are expressed by median (range);
Kruskal–Wallis test (comparability test Dunns).
Table 3: Association of FTO rs9939609 genotype with obesity-related traits.
Variables Estimated change per unit A allele (95% CI) 𝑝
Anthropometrics
Body weight (kg) 3.109 (0.392–5.827) 0.025
BMI (kg/m2) 1.735 (0.89–2.579) <0.001
WC (cm) 5.73 (3.58–7.88) <0.001
WHR 0.068 (0.047–0.089) <0.001
WHtR 0.041 (0.026–0.055) <0.001
NC (cm) 2.55 (1.45–3.65) <0.001
Overweight or obesitya 0.191 (0.102–0.361) <0.001
Central obesityb 0.328 (0.151–0.714) 0.005
Central obesityc 0.131 (0.068–0.253) <0.001
Visceral obesityd 0.12 (0.062–0.232) <0.001
Energy intake (kcal/day) 354.40 (231.71–477.10) <0.001
TSS (minutes/week) 190.52 (147.8–233.23) <0.001
R2D : 4D 0.018 (0.011–0.025) <0.001
L2D : 4D 0.016 (0.01–0.022) <0.001
Data presented as beta coefficient (for continuous outcome) or odd ratio (OR) (for binary outcome) with corresponding 95% confidence interval (CI). Models
were adjusted for age and sex; BMI: bodymass index, NC: neck circumference, WC: waist circumference, WHR: waist to hip ratio, WHtR: waist to height ratio,
R2D : 4D: ratio of the right hand second digit to the fourth, and L2D : 4D: ratio of the left hand second digit to the fourth; aoverweight or obesity was defined
as BMI ≥ 25.0 kg/m2; bcentral obesity was defined as WC > 80 cm for female and >94 cm for male; ccentral obesity was defined as WHR > 0.85 for female and
>0.90 for male; dvisceral obesity was defined asWHtR > 0.5.
𝑝 < 0.001) (path 𝑎1), energy intake (𝐵 = 240.73, t(198) =
5.71, and 𝑝 < 0.001) (path 𝑎2), and TSS (𝐵 = 84.35, t(197) =
5.44, and 𝑝 < 0.001) (path 𝑎3). Lastly, results indicated that
all mediator, TPA, energy intake, and TSS were associated
with BMI (𝐵 = −0.0005, t(196) = −2.79, and 𝑝 < 0.01 (path
𝑏1); 𝐵 = 0.0018, t(196) = 3.99, and 𝑝 < 0.01 (path 𝑏2);
and 𝐵 = 0.0068, t(198) = 5.33, and 𝑝 < 0.001 (path 𝑏3)),
respectively. Because all 𝑎 and 𝑏 paths were significant, mul-
tiple mediation analyses were tested using the bootstrapping
method with bias-corrected confidence estimates and 95%
confidence interval of the indirect effects was obtained with
5000 bootstrap resamples [32].
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Table 4: Association between FTO rs9939609 genotype and obesity measures by category of PA.
Variable Low PA (𝑛 = 77) 𝑝 Moderate PA (𝑛 = 75) 𝑝 High PA (𝑛 = 49) 𝑝 𝑝(FTO∗PA)OR (95% CI) OR (95% CI) OR (95% CI)
Overweighta 0.625 (0.181–2.159) 0.46 0.113 (0.033–0.387) 0.001 0.082 (0.009–0.736) 0.026 0.029
Central obesityb 0.78 (0.212–2.872) 0.71 0.273 (0.065–1.151) 0.077 0.187 (0.037–0.952) 0.043 0.345
Central obesityc 0.517 (0.174–1.539) 0.24 0.047 (0.011–0.194) <0.001 0.057 (0.01–0.323) 0.001 0.007
Visceral obesityd 0.356 (0.116–1.089) 0.07 0.039 (0.01–0.16) <0.001 0.142 (0.032–0.636) 0.011 0.010
Data presented as the odd ratio (OR) with corresponding 95% confidence interval (CI). Models were adjusted for age and sex; BMI: body mass index, WC:
waist circumference, WHR: waist to hip ratio, andWHtR: waist to height ratio; aoverweight or obesity was defined as BMI ≥ 25.0 kg/m2; bcentral obesity was
defined asWC > 80 cm for female and >94 cm for male; ccentral obesity was defined asWHR > 0.85 for female and >0.90 for male; dvisceral obesity was
defined asWHtR > 0.5.
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Figure 2: Effect of the FTO rs9939609 genotype on adiposity measures (body weight, BMI, and NC) stratified by category of PA. 𝑝 values are
for the interaction between the FTO variant and PA category; least-squares means of different genotypes across all PA groups were calculated
usingRobust Linear Regression analysis, after adjusting for age and sex. Allele frequency by PA categorywas low: 20/43/14;moderate: 28/34/13;
high: 27/13/9 for TT, TA, and AA genotypes, respectively. BMI: body mass index; NC: neck circumference. ∗Mean of each variable with
genotype for high PA is different from mean of each genotype for low PA at 𝑝 < 0.05 but not in NC TA and TT genotype.
Results of the mediation analysis of total indirect effect
confirmed the simultaneous mediating role of TPA, energy
intake, and TSS in the relation between FTO gene variant
and BMI (the total indirect effect was statistically significant
while unstandardized-coefficient = 1.68; 95% CI: 1.26–2.22).
Also, results indicated that the direct effect of FTO gene
variant on BMI was reduced drastically though significant
(𝐵 = −0.34, t(196) = −1.13, and 𝑝 > 0.05) (path 𝑐1) when
controlling for mediators, thus suggesting full mediation
(Figure 1). Each mediator (TPA, energy intake, and TSS)
was tested separately, and they all showed full mediating
ability on the interaction between FTO rs9939609 and BMI
(Supplementary Figures 5–7). Mediation model was created
for the effect of BMI on the association of FTO rs9939609
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using Robust Linear Regression analysis, with adjustment for age and sex. Allele frequency by PA category was low: 20/43/14; moderate:
28/34/13; high: 27/13/9 for TT, TA, and AA genotypes, respectively. WC: waist circumference, WHtR: waist to height ratio, and WHR; waist
to hip ratio. ∗Mean of each variable with genotype for high PA is different from the mean of each genotype for low PA at 𝑝 < 0.05 but not in
WC AA genotype and WHR TA genotype.
with TSS and TPA, and it showed that BMI exerts full
mediation in both cases (Supplementary Figures 8-9).
4. Discussion
In this pilot study, we analyzed SNP rs9939609 of the FTO
gene in a group of people with obesity and control in
Nigeria. Individuals with the FTO risk allele (A) and low
PA level had significantly high obesity risk factors (BMI,
WC, NC, WHR,WHtR, body weight, 2D : 4D, energy intake,
and TSS). Furthermore, PA, energy intake, and TSS play
a mediating role in the effect of the FTO gene variant to
BMI. These relationships indicate that the genetic variant
and some environmental variables (PA, TSS, and energy
intake) might be playing a relevant role in obesity. This study
thus elucidated the relationships between FTO genotype, PA,
anthropometrics, energy intake, and 2D : 4D in a population
residing in Nigeria. But further studies are required to
confirm or to refute these observations.
The AA genotype proportion of the FTO rs9939609
reported in this study was significantly higher in people with
obesity when compared with control (25.2% to 10.2%); this
is in agreement with earlier studies [8, 11, 33]. Our results
are in tandem with previous studies as carriers of risk alleles
showed higher obesity-related traits [8–11], thus confirming
the relationship between FTO rs9939609 and obesity.
This study reported a 1.74 (95% CI 0.47 to 1.10) kg/m2
increase in BMI per A allele. This is higher than 1.66, 1.55,
0.79, and 0.54 reported in France, Roma/Gypsy population,
and China and across seven European countries [10, 34–36]
but lower than 2.8 (95% CI 1.3–6.0) reported in Pakistan
female [37]. This shows that our result is comparable to what
was reported from other parts of the world. More so, our
result is not in agreement with Li et al. [38] that reported
no relationship between FTO rs9939609 and BMI in Chinese
Han population; this discrepancy might be due to difference
in environmental variables, obesity categorization, ethnic
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Figure 4: Effect of the FTO rs9939609 genotype on energy intake, TSS, and R2D : 4D stratified by category of PA. 𝑝 values are for the
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𝑝 < 0.05 but not in R2D : 4D TT and AA genotype.
difference, and their low MAF, thereby making it having
little power to affect obesity in that region. In this study, we
reported MAF of 40%, slightly similar to 35.54 reported in
Gambia by Hennig et al. [20], higher than (12.1%) reported
in China by [36, 38], and lower than (∼45%) reported among
European population [8].
Similarly, this study shows that FTO rs9939609 A allele
carriers had an increased risk (odds) of overweight/obesity
[OR = 0.19 (95% CI: 0.10, 0.36); 𝑝 < 0.001], central obesity
[OR = 0.33 (95% CI: 0.15, 0.71); 𝑝 < 0.001], and visceral
obesity [OR = 0.12 (95% CI: 0.06, 0.23); 𝑝 < 0.001] compared
with the TT homozygotes. This is less than the results
from other studies across seven European countries [10] and
France [34]. The reason might be due to the difference in
sample size power, environmental variables, central obesity
categorization, and variants in data collection procedure
and to different linkage disequilibrium patterns across FTO
intron 1 between the various ethnic groups, particularly in
populations of African ancestry [4, 5]. Subsequently, our
study suggests that the odds of being overweight/obesity was
substantially attenuated by active lifestyle (PA).This is similar
to other studies that showed that PAmightmitigate the effects
of gene variant FTO rs9939609 on obesity [10, 19, 36, 39].
But contrary to what was reported in Finland, they reported
leisure-time PA [40]. We also reported A allele-dependent
increase in energy intake and TSS; this is in line with some
recent works [9, 14].
From the foregoing, we might infer that environmental
variables (PA, energy intake, and TSS) might have a mediat-
ing role in the interaction between FTO rs9939609 and BMI,
mediation analysis. Results frommultiple mediation analysis
showed that all our environmental variables have a full
mediating effect on the interaction between FTO rs9939609
and BMI; this is incongruent with other studies by [9, 14, 31].
Studies have shown the importance of both FTO
rs9939609 and 2D : 4D as a surrogate marker for obesity and
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coronary heart disease [8–11, 16–18] but none have studied
the relationship between them. We reported an association
between FTO gene variant and 2D : 4D with individual car-
rying FTO risk allele having increased 2D : 4D; thus 2D : 4D
might be used to predict individual FTO rs9939609 genotype
in future, but further studies are required to buttress and
refute this.
Full role of FTOfirst intron rs9939609 on obesity etiology
and their role in energy expenditure need more to be done.
Speakman [6] reported that there is inconclusive evidence
(like epistatic or gene-environment interaction) in the rela-
tionship between FTO, PA, and energy expenditure. Thus,
we can explore gene-environment interaction to demystify
biology of FTO.
This study presents evidence about the role of genetic
variant and gene-environment interaction concerning obe-
sity in a Nigerian youth population which is based case-
control study with good response rate and low selection
bias. Also, our study had the power to detect the association
of rs9939609 with obesity in Nigerian youth. However,
several limitations should also be noted. First, this study
was carried out in a Polytechnic campus which might affect
response to some parameters like PA because the layout of the
school seems to encourage PA. Second, we need an objective
measure of environmental variables like accelerometer for
PA to be sure of the PA level. Lastly, only one SNP of
FTO was measured in this study, so it is unclear whether
the identified association is due to this particular sequence
variant or another variant in tight linkage disequilibriumwith
rs9939609 [40].
Power value (95%) andBonferroni correction formultiple
testing used in this study reduce both the risk of false
positive and false negative results; thus we might draw some
conclusion from our results. Nigeria relies on results from
other parts of the world on the interaction of genetic and
environmental impact on obesity; this might not be good
because studies have shown variations from the different
ethnic population [2–5].Thus this study made an indigenous
genetic study of obesity available, thus paving the way
for proper management of obesity because PA, TSS, and
energy intake showed modulating/mediating effect on the
interaction between FTO and obesity. Lastly, such evidence
of gene-environmental/lifestyle interaction will be of great
importance because environment/lifestyle can be modified
easily unlike gene that is inherent in the particular popula-
tion.
5. Conclusions
Our study suggests that environmental/lifestyle factors like
PA, TSS, and energy intake might be substantial modulator
and/or mediator in the association between FTO rs9939609
and BMI in Nigeria because they mediate the influence of
FTO variant on BMI, offering new insight into the interrela-
tionship between FTO genetic variants, TPA, energy intake,
and TSS in Nigeria. Our data attest the previously reported
association regarding the genetic variability in intron 1 of
FTO gene and obesity risk. This might propose a mechanism
of understanding of FTO-linked weight gain and obesity in
the Nigerian context, but further study with larger sample
size and objective measures of environmental variable is
warranted.
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